Abundance and variation of gaseous NH3 in relation with inorganic fertilizers and soil moisture during Kharif and Rabi season.

In an agricultural country like India, inorganic fertilizers are the major contributors of atmospheric NH3 in rural areas affecting soil, vegetation and water bodies. In this study, day-night and seasonal variation of ammonia emissions were measured from July 2017 to June 2018 during Kharif and Rabi crop seasons at a rural agricultural site in Jhajjar district of Haryana. Also, NH3 emission inventory is prepared for the amount of fertilizers applied during its basal and top dressing. NH3 concentrations were noticed significantly lower after basal dressing of DAP fertilizers as compared to the concentrations after top dressing of urea. NH3 concentration in air increased with decrease in water saturation of the soil. NH3 emission was recorded as 1.4 to 45.2, 63.1 to 190.9, and 98.9 to 187.5 µg m-3 during sowing, fertilizer addition, and grain filling stages, respectively, in Kharif season. Apart from these crop stages, NH3 was measured as 56.8 to 249.5 µg m-3 during crop residue burning period. On the other hand, NH3 emissions ranged from 22.9 to 68.4, 59.4 to 104.71, 26.3 to 56.0, 48.2 to 147.2, and 21.5 to 80.4 µg m-3 during sowing, crown root initiation (CRI), panicle initiation, grain filling, and maturity crop, respectively, in Rabi season. The average NH3 concentrations during Kharif season (125.3 µg m-3) were significantly greater than the concentrations during Rabi season (51.8 µg m-3). However, a reduction in the NH3 values was observed in the period between Kharif and Rabi seasons, which could be attributed to the wet deposition during monsoon and gas to particle conversion due to less temperature conditions during the periods.

Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.

Designing drug candidates exhibiting polypharmacology is one of the strategies adopted by medicinal chemists to address multifactorial diseases. Metabolic disease is one such multifactorial disorder characterized by hyperglycaemia, hypertension and dyslipidaemia among others. In this paper we report a new class of molecular framework combining the pharmacophoric features of DPP4 inhibitors with those of ACE inhibitors to afford potent dual inhibitors of DPP4 and ACE.

Report of chronic myeloid leukemia SMS Medical College Hospital, Jaipur.

This is a retrospective analysis of patients of chronic myeloid leukemia (CML) registered and under treatment at the Leukemia Lymphoma Clinic at the Birla Cancer Center, SMS Medical College Hospital, Jaipur. Approximately, two-thirds of the patients are getting imatinib mesylate (IM) through the Glivec International Patient Assistance Program while the rest are on generic IM. In addition to comparison of hematological and molecular responses in the Glivec versus the genetic group, in this analysis, an attempt is also made to assess the socio-economic (SE) status of the patients and its effect on the response rates. Of the 213 patients studied, most (28.6%) are in the age group between 30 years and 40 years and the mean age of the patients in 39 years, a good decade younger that in the west. There is a suggestion that patients in lower SE class present with higher Sokal scores and with more disease burden. Possibly hematological responses are similar with both Glivec and generic IM. No comment can be made with regards to molecular response between the two groups as a significant number of patients in the Glivec arm (42%) do not have molecular assessment because of economic reasons. CML is a common and challenging disease in the developing world with patients presenting at an earlier age with more advanced disease. SE factors play a significant role in therapy and disease monitoring decision making and may impact on response rates and prognosis.